Cargando…
Risk communication on vaccines during the COVID19 pandemic: is there room for small size or private initiatives? An Israeli experience
The scientific communication landscape has undergone a significant disruption since the COVID-19 pandemic: a huge number of publications, ample use of preprint publications, a fast-spreading digitalized information. This reflected the unprecedented speed of the research on disease and vaccines. Two...
Autores principales: | Fermont, Irene R., Livneh, Ayalah, Benhamou, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358549/ https://www.ncbi.nlm.nih.gov/pubmed/35958047 http://dx.doi.org/10.1177/20420986221112189 |
Ejemplares similares
-
Impact of risk communication on patient’s safety during the
pandemic
por: Zuluaga-Arias, Heyde-Patricia, et al.
Publicado: (2023) -
The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk
por: Quintero, Gustavo A.
Publicado: (2022) -
Self-medication and the ‘infodemic’ during mandatory preventive
isolation due to the COVID-19 pandemic
por: Gaviria-Mendoza, Andrés, et al.
Publicado: (2022) -
Drug safety of frequently used drugs and substances for self-medication in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022) -
Alkalising agents in urinary tract infections: theoretical contraindications, interactions and synergy
por: Kavanagh, Oisín N.
Publicado: (2022)